Aron R. English - 23 May 2025 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 May 2025, 20:06:01 UTC
Prior SEC filing
16 May 2025
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aron R. English

Key filing fact

Aron R. English filed Form 4 for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) on 28 May 2025.

Key facts

  • This page summarizes Aron R. English's Form 4 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 28 May 2025, 20:06.

Change

  • Previous filing in this sequence was filed on 16 May 2025.
  • Current net transaction value: -$9,132,503.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (5)

CIK 0001770436 Primary reporting owner

English Aron R.

Relationship
10%+ Owner
Address
590 1ST AVE. S UNIT C1, SEATTLE
Signature
/s/ Aron R. English
Signature date
28 May 2025
CIK 0001694297

22NW, LP

Relationship
10%+ Owner
Address
590 1ST AVE. S UNIT C1, SEATTLE
Signature
22NW Fund, LP; By: 22NW Fund GP, LLC; By: /s/ Aron R. English, Manager
Signature date
28 May 2025
CIK 0001640809

22NW Fund, LP

Relationship
10%+ Owner
Address
590 1ST AVE. S UNIT C1, SEATTLE
Signature
22NW, LP; By: 22NW GP, Inc.; By: /s/ Aron R. English, President and Sole Shareholder
Signature date
28 May 2025
CIK 0001770575

22NW Fund GP, LLC

Relationship
10%+ Owner
Address
590 1ST AVE. S UNIT C1, SEATTLE
Signature
22NW Fund GP, LLC; By: /s/ Aron R. English, Manager
Signature date
28 May 2025
CIK 0001783663

22NW GP, Inc.

Relationship
10%+ Owner
Address
590 1ST AVE. S UNIT C1, SEATTLE
Signature
22NW GP, Inc., By: /s/ Aron R. English, President and Sole Shareholder
Signature date
28 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFCR transaction

Common Stock

Sale

Transaction value
$649,386
Shares
-96,137
Change %
-5.8%
Price
$6.75
Shares after
1,554,103
Date
23 May 2025
Ownership
By: 22NW Fund, LP
Footnotes
F1, F2, F3
LFCR transaction

Common Stock

Sale

Transaction value
$7,411,562
Shares
-1,139,504
Change %
-73%
Price
$6.50
Shares after
414,599
Date
27 May 2025
Ownership
By: 22NW Fund, LP
Footnotes
F1, F3, F4
LFCR transaction

Common Stock

Sale

Transaction value
$1,071,555
Shares
-150,419
Change %
-36%
Price
$7.12
Shares after
264,180
Date
28 May 2025
Ownership
By: 22NW Fund, LP
Footnotes
F1, F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Aron R. English is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Footnote F2

Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.7500 to $6.7800, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

Footnote F4

Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.500 to $6.900, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9000 to $7.5000, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .